Helix Acquisition Corp II

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Helix Acquisition Corp II
TickerBBOT
CIK #0001869105
CUSIP107924102
SectorReal Estate & Construction - Blank Checks
Addressc/o Cormorant Asset Management, LP 200 Clarendon Street, 52Nd Floor, Boston, MA 02116
Source [EDGAR]
CIK Filing 2011 - 2026
[0001869105] 10-K
[0001869105] 10-Q
[0001869105] 3
[0001869105] 4
[0001869105] 8-K
[0001869105] SC 13D
[0001869105] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Bridgebio Pharma LLC Bridgebio Oncology Therapeutics Inc [2025-08-18] 0.0
Flynn James E Bridgebio Oncology Therapeutics Inc [2025-08-18] 0.0
Sculptor Capital LP Helix Acquisition Corp II [2025-07-24] 0.0
BlackRock Portfolio Management LLC Helix Acquisition Corp II [2025-04-15] 0.0
Price T Rowe Associates Inc /MD/ Helix Acquisition Corp II [2024-11-14] 6.0
BlackRock Inc Helix Acquisition Corp II [2024-11-08] 7.9
BlackRock Inc Helix Acquisition Corp II [2024-10-22] 7.9
Citadel Advisors LLC Helix Acquisition Corp II [2024-02-23] 7.0
Adage Capital Partners GP LLC Helix Acquisition Corp II [2024-02-23] 7.4
Helix Holdings II LLC Helix Acquisition Corp II [2024-02-20] 21.4
Integrated Core Strategies US LLC Helix Acquisition Corp II [2024-02-15] 5.0
Form 3/4/5 Filer 2011 - 2026
BridgeBio Oncology Therapeutics, Inc.
Beltran Pedro
Ben Yong
Elmelech Idan
Cobo Marc
Chen Bihua
Kelleher Raymond J.
Lebowitz Peter F
McCormick Frank
Tipirneni Praveen P.
Kumar Neil
Bauer Jake
Mehra Uneek
Wallace Eli M.
BridgeBio Pharma LLC
BridgeBio Pharma, Inc.
DOIG Michelle
Schmid John P.
McKenna Mark C.
Holman Albert A III
Tripp Caleb
Obradovic Nebojsa
Helix Holdings II LLC
Form 13F Holdings
Firm Period DFND Voting Shares
TEMA ETFS LLC [2026-06-30] SOLE 93,339 93,339
Prev | Page 3 | Next
Terms | Privacy | Guide
tony@aum13f.com